NEW YORK (GenomeWeb News) - Illumina has won the first phase of a trial that involves plaintiff Applied Biosystems and defendants Illumina, Solexa, and ABI's former IP counsel Stephen Macevicz regarding ownership of intellectual property relating to ABI's SOLiD sequencing system, GenomeWeb Daily News has learned.

An Illumina spokeswoman confirmed by e-mail today that "a federal jury has determined that Illumina owns the patents that are the subject of the suit with Applied Biosystems, and that the case has now moved on to the infringement phase."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.